Articles, guides, and regulatory updates from our community.
New research reveals how telehealth rules, NP authority, and compounding infrastructure create major geographic gaps in peptide-based sexual medicine access.
By Peptide Association Research Team
New research finds where you live—not just federal policy—may determine your access to peptide-based sexual medicine therapies. Here's what the data shows.
By Peptide Association Research Team
New 2026 research reveals wide geographic disparities in access to peptide-based sexual medicine therapies driven by state telehealth, NP, and compounding laws.
By Peptide Association Research Team
New research identifies a novel chemical impurity in compounded tirzepatide/B12 products. Learn what this means for patient safety and informed treatment decisions.
By Peptide Association Research Team